LibraryCardiology· 50 of 138
Cardiology

Congenital Heart Disease — Coarctation of the Aorta

~11 min read8 sections
⭐ High-yield🎯 Drill Cardiology
Contents (8)

Coarctation of the aorta (CoA) is a congenital narrowing of the descending thoracic aorta, typically occurring just distal to the left subclavian artery at the level of the ligamentum arteriosum. It accounts for 5–8% of all congenital heart disease and is the most common cause of secondary hypertension in children. Two morphologic variants exist: infantile (preductal) type, in which the narrowing occurs proximal to the ductus arteriosus, and adult (postductal) type, occurring distal to the ductus. The condition is strongly associated with Turner syndrome (45,X), occurring in up to 15% of Turner patients, and less commonly with Marfan syndrome, Ehlers-Danlos syndrome, and bicuspid aortic valve. Clinical presentation ranges from asymptomatic discovery in childhood to severe heart failure in infancy depending on the degree of obstruction and ductal patency.

The fundamental pathophysiology of coarctation involves obstruction-induced pressure gradient across the narrowed aortic segment, creating differential hemodynamic consequences above and below the lesion:

  • Proximal hemodynamic consequences: The narrowing creates increased resistance to left ventricular outflow, resulting in left ventricular pressure overload and compensatory left ventricular hypertrophy (LVH). The proximal aorta experiences elevated systolic and diastolic pressures, causing systemic hypertension in the upper extremities. The increased afterload stimulates baroreceptor reflexes and activates the renin-angiotensin-aldosterone system (RAAS), perpetuating hypertension even after surgical relief in some patients (suggesting "resetting" of baroreceptor sensitivity).
  • Distal hemodynamic consequences: Distal to the obstruction, aortic pressure and organ perfusion are reduced. This triggers compensatory collateral circulation through enlarged intercostal arteries, internal mammary arteries, and thyrocervical trunk vessels—a process that develops gradually over years and explains why infants with critical coarctation present with shock while older children tolerate narrowing better. In preductal coarctation, the patent ductus arteriosus provides crucial right-to-left shunting, supplying the descending aorta; ductal closure precipitates cardiovascular collapse in neonates.
  • Cellular and molecular basis: The obstruction reflects abnormal neural crest cell migration during weeks 6–9 of gestation, leading to increased smooth muscle cellularity and reduced elastin content in the aortic wall. Genetic associations include NOTCH1 mutations and dysregulation of vascular smooth muscle cell proliferation. The narrowed segment exhibits medial hypertrophy with disrupted elastic fibers and occasionally associated hypoplasia of the aortic isthmus (the narrow region between the left subclavian artery and ligamentum arteriosum).

Genetic and syndromic associations

  • Turner syndrome (45,X): 15% prevalence; screen all Turner patients with echocardiography
  • Marfan syndrome: Fibrillin-1 mutation affecting elastic fiber integrity
  • Ehlers-Danlos syndrome: Connective tissue disorder with associated vascular fragility
  • Bicuspid aortic valve: Present in 85% of CoA patients; shared embryologic origin
  • Hypoplastic left heart syndrome and other left-sided obstructive lesions: Sequential development

Other syndromic associations

  • Down syndrome (trisomy 21)
  • Williams syndrome (7q11 deletion)
  • Noonan syndrome (PTPN11 mutations)

Sporadic/non-syndromic: Majority of cases; multifactorial inheritance pattern with recurrence risk of 2–3% in offspring

Maternal risk factors

  • Maternal age >40 years
  • Maternal phenylketonuria (PKU) with poor dietary control

Presentation varies dramatically with degree of obstruction and age at presentation:

Neonatal/Infantile presentation (preductal CoA with critical obstruction)

  • Severe cardiogenic shock in first 1–2 weeks of life after ductal closure
  • Poor feeding, failure to thrive, irritability
  • Respiratory distress, pulmonary edema
  • Peripheral hypoperfusion, weak or absent femoral pulses (pathognomonic finding)
  • Metabolic acidosis from tissue hypoperfusion

Childhood/Adolescent presentation (postductal CoA or less severe obstruction)

  • Often asymptomatic and discovered incidentally on blood pressure screening
  • Hypertension in upper extremities; may be accompanied by headaches, epistaxis
  • Leg claudication or exercise-induced leg pain (from inadequate lower extremity perfusion during increased metabolic demand)
  • Dyspnea on exertion from LV dysfunction

Physical examination findings

  1. Blood pressure differential: Systolic BP in upper extremities >20 mmHg higher than lower extremities (measured in legs using appropriately sized cuff); femoral pulses delayed relative to radial pulses (radio-femoral delay—classic, highly specific finding)
  1. Pulse characteristics: Femoral and popliteal pulses weak, delayed, or absent; brachial pulses bounding (from LVH and increased stroke volume)
  1. Cardiac examination:
  • Systolic ejection murmur at left infraclavicular region or back (from turbulent flow across narrowing or from associated bicuspid aortic valve stenosis)
  • Narrow pulse pressure in lower extremities
  • Signs of LVH: sustained, laterally displaced PMI
  • Diastolic decrescendo murmur if bicuspid aortic valve regurgitation present
  1. Neurologic examination: Signs of Turner syndrome (short stature, webbed neck, shield chest, broad carrying angle)
  1. Vascular findings: Visible intercostal pulsations (enlarged collateral vessels), dilated chest wall veins

Clinical suspicion triggers

  • Hypertension in child or young adult
  • Differential blood pressure between arms and legs
  • Femoral pulse abnormality or radio-femoral delay
  • Associated findings: Turner syndrome, bicuspid aortic valve, or other syndromic features
  • Screening in asymptomatic siblings of affected patients

Imaging modalities (in order of typical clinical use)

  1. Chest X-ray (CXR):
  • Three-sign ("E sign"): Indentation of aortic knob with pre- and post-stenotic aortic dilation
  • Rib notching: Erosions of ribs 3–8 from enlarged intercostal arteries (develops over years; indicates chronic coarctation)
  • LVH with increased cardiothoracic ratio in severe cases
  • Signs of congestive heart failure (pulmonary edema, pleural effusion) in neonates
  1. Transthoracic echocardiography:
  • First-line imaging modality for diagnosis and follow-up
  • Parasternal long-axis and short-axis views demonstrate narrowing of descending aorta
  • Continuous-wave Doppler: Quantifies pressure gradient across narrowing; gradient >30 mmHg systolic considered significant
  • Assess LV size, wall thickness, and systolic function
  • Identify bicuspid aortic valve (present in 50–85% of CoA patients)
  • Assess for associated cardiac lesions (mitral valve disease, ventricular septal defect)
  • Limitations: Difficult imaging of aortic arch in older children/adults with good lung windows; cannot visualize entire aorta in many patients
  1. Cardiac MRI (gold standard for anatomic delineation):
  • High-resolution imaging of entire aorta including arch anatomy
  • Accurate measurement of narrowing diameter and length
  • Quantification of flow using phase-contrast techniques
  • Assessment of collateral circulation
  • Evaluation for associated aortic abnormalities (hypoplastic isthmus, aortic stenosis, interrupted aortic arch)
  • No radiation exposure
  • Limitations: Longer acquisition time; contraindication in patients with metallic implants
  1. CT angiography:
  • Alternative when MRI contraindicated
  • Rapid acquisition; excellent spatial resolution
  • Radiation exposure consideration
  • Useful for post-intervention imaging
  1. Cardiac catheterization:
  • Rarely needed for diagnosis in modern practice
  • Indicated when gradient assessment by non-invasive imaging is inconclusive or discordant with clinical presentation
  • Direct pressure measurement with simultaneous recordings from proximal and distal aorta
  • Allows coronary angiography in adults pre-intervention
  • Can serve as therapeutic intervention (balloon angioplasty, stent placement)

Laboratory findings

  • ECG: LVH with strain pattern (T-wave inversions in lateral leads); may show left axis deviation
  • BNP/NT-proBNP: Elevated in heart failure; useful for risk stratification
  • Renal function and electrolytes: Assess for hypertension-related end-organ damage
  • Urinalysis: Screen for proteinuria from hypertensive nephropathy

Diagnostic criteria for hemodynamically significant CoarCtation

  • Peak systolic pressure gradient >20 mmHg at rest (some sources: >30 mmHg)
  • Diastolic run-off: Continuous diastolic flow in descending aorta on Doppler (indicates severe narrowing)
  • Ratio of narrowed segment diameter to aorta at diaphragm <0.5
  • Left ventricular hypertrophy with dysfunction

Treatment approach depends on age, symptomatology, gradient magnitude, and associated lesions:

First-Line Interventional Therapy (Definitive)

Indications for intervention

  • Symptomatic patients at any age
  • Asymptomatic children with resting gradient ≥30 mmHg (some centers: ≥20 mmHg) or significant LVH
  • Asymptomatic adults with gradient ≥20 mmHg or evidence of LV dysfunction
  • Neonates/infants with critical coarctation: Emergency intervention required

Surgical repair (traditional gold standard)

  • Indication: Primary therapy for most neonates, infants, and young children; still used for complex anatomy or recurrent stenosis
  • Techniques:
  1. End-to-end anastomosis: Excision of narrowed segment with direct anastomosis (preferred in infants)
  2. Subclavian flap angioplasty: Division of left subclavian artery at origin; artery reflected and opened longitudinally to patch narrowing (Waldhausen procedure); useful in infants but causes left arm ischemia (usually clinically insignificant due to collaterals)
  3. Interposition graft: Dacron tube or other conduit placed between proximal and distal aorta; used when direct anastomosis not feasible
  4. Extended end-to-end anastomosis: Extends anastomosis to include hypoplastic isthmus
  • Advantages: Excellent long-term outcomes; single definitive procedure with native tissue
  • Disadvantages: Surgical morbidity; requires general anesthesia; risk of residual/recurrent stenosis (5–20% in neonatal repairs); need for re-intervention in children (growth-related)
  • Complications: Spinal cord ischemia (0.4% risk), hypertension paradoxes, chylothorax, vocal cord paralysis

Percutaneous intervention (balloon angioplasty/stent)

  • Indication: Increasingly first-line in older children and adolescents; primary therapy for recurrent CoA
  • Balloon angioplasty alone:
  • Immediate relief of gradient; good short-term outcomes
  • Restenosis risk 10–15% in native CoA; higher in early post-surgical restenosis
  • Aortic rupture risk 0.5–2% (catastrophic complication)
  • Aortic dissection risk
  • No longer recommended as monotherapy due to restenosis
  • Stent placement (now preferred percutaneous approach):
  • Covered stents (e.g., Cheatham-Platinum CP stent) preferred to reduce aortic rupture risk
  • Excellent acute relief of obstruction
  • Restenosis rates 0–5% at 2 years
  • Ability to redilate with growth in children (major advantage)
  • Lower complication rates compared to angioplasty alone
  • Disadvantages: Stent thrombosis (rare); difficulty crossing severely hypoplastic segments; need for larger access vessels
  • Hybrid approach: Combined surgical and catheter-based techniques for complex anatomy

Medical Management (Adjunctive, not definitive)

Antihypertensive therapy

  • ACE inhibitors (lisinopril, enalapril) or ARBs (losartan): First-line agents; reduce afterload and may regress LVH
  • Beta-blockers (atenolol, metoprolol): Reduce systolic pressure and cardiac workload; useful in neonates with critical CoA as bridge to surgery/intervention
  • Calcium channel blockers (amlodipine, nifedipine): Alternative or adjunctive agent
  • Diuretics (furosemide): For heart failure management if LV dysfunction present
  • Vasodilators (hydralazine, nitroprusside): For acute hypertensive crisis in perioperative period
  • Alprostadil (PGE1): In neonates with critical preductal CoA and ductal dependence; keeps ductus arteriosus patent, maintains lower body perfusion while awaiting surgery (initial dose 0.05 mcg/kg/min IV, titrate up; watch for apnea)

Note: Medical therapy alone does NOT cure coarctation and cannot prevent LVH progression or complications; intervention is required for definitive treatment.

Non-Pharmacological Measures

  • Activity restriction: Avoid competitive sports and activities with sustained high blood pressure elevations until treated
  • Blood pressure monitoring: Regular measurement in all extremities
  • Lifestyle modification: Sodium restriction, weight management (if overweight), stress reduction

Post-Intervention Monitoring

  • Serial echocardiography: Every 6–12 months acutely post-intervention; annually long-term to assess gradient, LVH regression, aortic valve disease
  • Blood pressure surveillance: May persist despite successful intervention (up to 30% remain hypertensive); requires ongoing pharmacotherapy
  • Cardiac MRI: At 1 month and then annually or as clinically indicated to assess for residual/recurrent stenosis, aortic aneurysm formation
  • Exercise stress testing: Prior to clearance for sports participation

Immediate/Perioperative complications

  1. Spinal cord ischemia/paraplegia: Occurs in 0.4% of surgical repairs
  • Risk factors: Extensive collateral dependence, long segment repair, multiple proximal cross-clamp
  • Prevention: Limit aortic cross-clamp time, consider left heart bypass, maintain proximal perfusion pressure
  • Management: Supportive care; may improve over time if partial injury
  1. Aortic rupture: During balloon angioplasty (0.5–2% incidence)
  • More common in native CoA with thin aortic wall
  • Prevention: Use covered stents; avoid excessive balloon inflation
  • Management: Emergency surgical repair or ECMO support
  1. Hypertensive crisis: Exaggerated blood pressure response immediately post-intervention
  • Mechanism: Sudden reversal of obstruction; baroreceptor dysfunction
  • Management: Vasodilators, beta-blockers, careful ICU monitoring
  1. Chylothorax: From damage to thoracic duct (surgical approach)
  • Management: Chest tube drainage; dietary modification (medium-chain triglycerides); rarely requires ligation
  1. Vocal cord paralysis: From left recurrent laryngeal nerve injury (surgical)
  • Incidence: 1–2%; usually transient
  • Clinical significance: Hoarseness, weak cry in infants

Long-term complications

  1. Residual/recurrent coarctation: 5–25% depending on initial technique
  • Higher risk with neonatal repair (growth-related)
  • May require re-intervention with balloon dilation or re-operation
  1. Hypertension: Pers

  • Upper-extremity hypertension with weak, delayed femoral pulses is the stem's giveaway. Radio-femoral delay plus an arm-to-leg systolic difference is coarctation until proven otherwise — do not settle for "essential hypertension" in a teenager or "peripheral arterial disease" in a young adult.
  • Single best next step in a stable patient: transthoracic echocardiography with suprasternal-notch Doppler. CXR and ECG support the diagnosis but do not make it; the ACC/AHA adult congenital heart disease guideline positions echo first, with CMR or CTA when the arch is not adequately seen.
  • Neonate in shock after the first week of life: the ductus closed. Start a prostaglandin E1 infusion (alprostadil) to reopen/maintain ductal patency and restore lower-body perfusion before imaging or transfer — apnea is the expected side effect. This is the highest-yield "next step" in the neonatal version of the stem.
  • Buzzwords: inferior rib notching (ribs 3–8, from dilated intercostal collaterals — takes years, so absent in infants and it spares ribs 1–2, which are fed by the costocervical trunk) and the "3 sign" on CXR.
  • The association examiners test most: bicuspid aortic valve — the single most common lesion accompanying coarctation. The syndromic association tested most is Turner syndrome (45,X); every Turner patient warrants screening echocardiography.
  • Berry aneurysms of the circle of Willis are the classic extracardiac association; a young hypertensive with coarctation and thunderclap headache is subarachnoid hemorrhage.
  • Common distractor — "repaired means cured." A substantial minority remain hypertensive after successful repair (baroreceptor resetting, RAAS activation), and recoarctation, aortic aneurysm, and premature coronary disease mandate lifelong follow-up at an adult congenital heart disease center.
  • Measure the right arm. If the coarctation involves or lies proximal to the left subclavian origin, left-arm pressure is falsely low and the gradient is missed.

Related topics

← Back to library